Mallinckrodt Pharmaceuticals

Listening for Needs. Delivering Solutions

Where others see complexity, we see potential for growth.

Our Products

Producing high-quality, specialty treatments


A rich history of innovation & patient-centered solutions

We develop, manufacture, market and distribute specialty treatments.

Our values guide our work and serve as a foundation for our success.

Years of Expertise
Employees Worldwide
0 +
young adult man holding a newborn baby in hospital
Years Of Expertise
0 +
About Us

Solving complex challenges with a diverse product portfolio

Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products.

Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology; neonatal critical care respiratory therapies; and analgesics and hemostasis products.

The company’s Specialty Brands segment includes branded medicines/devices; and its Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients.


You are now leaving the Mallinckrodt Canada site

Users agree that access to and use of any website linked from this site and the content of either is at their own risk. Mallinckrodt Canada shall not be liable in any matter whatsoever for any direct, incidental, consequential, indirect or punitive damages arising from the access to, use of, or inability to use this website or any website linked to this site or for any errors or omissions in the content of either this website or any website linked to this site.